The immune-cardiovascular metabolic circuitry in myocardial ischemia-reperfusion injury: from metabolic signal release to spatiotemporal reprogramming - Scorecard - MDSpire

The immune-cardiovascular metabolic circuitry in myocardial ischemia-reperfusion injury: from metabolic signal release to spatiotemporal reprogramming

  • By

  • Conghao Tan

  • Junjie Zhou

  • Jiawen Li

  • Xinyi Zhang

  • Wei Yuan

  • May 26, 2026

  • 0 min

Share

Clinical Scorecard: The Interplay of Immune and Cardiovascular Metabolism in Myocardial Ischemia-Reperfusion Injury: From Metabolic Signal Release to Temporal Reprogramming

At a Glance

CategoryDetail
Condition
Key MechanismsDysregulated immune-cardiac metabolic communication involving metabolic signal release and immune cell reprogramming. [Needs citation]
Target PopulationPatients experiencing acute myocardial infarction and subsequent reperfusion therapy. [Needs citation]
Care SettingClinical settings involving acute myocardial infarction management. [Needs citation]

Key Highlights

  • MIRI is characterized by an imbalance in immune-cardiac metabolic communication. [Needs citation]
  • Injured cardiac cells actively release metabolites that influence immune responses. [Needs citation]
  • Immune cells dynamically reprogram their metabolism in response to cardiac signals. [Needs citation]
  • Temporal and spatial contexts are critical in determining the outcomes of MIRI. [Needs citation]
  • Emerging techniques like single-cell omics may guide targeted therapies. [Remove or support with citation]

Guideline-Based Recommendations

Diagnosis

  • Recognize MIRI as a significant determinant of infarct size and clinical outcomes post-reperfusion. [Needs citation]

Management

  • Consider the role of metabolic signals in shaping immune responses during MIRI. [Needs citation]

Monitoring & Follow-up

  • Evaluate metabolic disturbances and immune responses in patients undergoing reperfusion therapy. [Needs citation]

Risks

  • Be aware that reperfusion can trigger oxidative stress and inflammation, exacerbating myocardial injury. [Needs citation]

Patient & Prescribing Data

Mechanism-based therapies targeting immune-cardiac metabolic interactions are needed. [Needs citation]

Clinical Best Practices

  • Assess the metabolic state of both cardiac and immune cells in MIRI. [Needs citation]
  • Utilize spatial and temporal data to inform therapeutic strategies. [Needs citation]

Related Resources & Content

    Original Source(s)

    The immune-cardiovascular metabolic circuitry in myocardial ischemia-reperfusion injury: from metabolic signal release to spatiotemporal reprogramming

    • by Conghao Tan, Junjie Zhou, Jiawen Li, Xinyi Zhang, Wei Yuan

    • May 26, 2026

    Related Content

    Tirofiban After Tenecteplase in Stroke

    Adjunctive tirofiban was linked to higher rates of positive 90-day outcomes in acute ischemic stroke.

    Serum Urate Goals Tied to Lower CV Risk

    Patients with gout who reached serum urate targets had modestly higher 5-year cardiovascular event-free survival, with associations strongest among high-risk patients

    GLP-1 Drugs Tied to Lower Addiction Risk

    In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.